GLP-1 Access by StateNV

GLP-1 Weight Loss Medications in Nevada

Find telehealth providers, insurance coverage, and affordable GLP-1 options across Nevada.

Telehealth Prescribing

Allowed

Restrictions

Nevada passed SB 5 (2021) making telehealth access permanent. Providers must be licensed in Nevada. The state accepts Interstate Medical Licensure Compact credentials. No geographic or originating-site restrictions apply — patients can receive telehealth from home.

Prescribing Rules

Non-controlled medications including GLP-1 receptor agonists can be prescribed via telehealth without an in-person encounter. Nevada law requires a synchronous audio-video visit for initial prescriptions. NPs and PAs with prescriptive authority can also prescribe GLP-1s via telehealth.

Insurance Coverage

Medicaid Coverage

Yes (expanded)

Prior Authorization

Typically required

Major Insurers

Prominence Health PlanSierra Health and Life (UHC)Anthem Blue Cross Blue Shield of NevadaHealth Plan of Nevada

Nevada expanded Medicaid in 2014. Nevada Medicaid covers GLP-1s for diabetes; weight management coverage has been gradually expanding. AB 317 (2023) mandated commercial insurers cover FDA-approved anti-obesity medications, though prior authorization is still permitted.

Cost Breakdown

Brand Name

$900-$1400

per month, without insurance

Compounded

Available

$150-$450

per month

Top Providers in Nevada

Calibrate

Telehealth

Comprehensive metabolic health program with GLP-1 prescribing available to Nevada residents.

Southwest Medical Associates

Both

Large multi-specialty group in Las Vegas with weight management services and telehealth options.

Ro

Telehealth

Ships compounded semaglutide to Nevada; offers body program with ongoing provider support.

Nevada Telehealth Regulations

Nevada has one of the more progressive telehealth frameworks in the West. SB 5 eliminated pandemic-era sunset clauses and established permanent telehealth parity. The state allows patients to receive care from home without geographic restrictions, which is important for residents outside the Las Vegas and Reno metro areas. Clark County has strong provider density, but rural Nevada counties like Elko, Humboldt, and Pershing are classified as medically underserved.

Insurance Coverage After AB 317

Nevada made significant progress in 2023 with AB 317, which requires commercial health insurers to cover FDA-approved anti-obesity medications. This includes semaglutide (Wegovy) and tirzepatide (Zepbound) when prescribed for weight management. Insurers can still require prior authorization and step therapy, but they cannot issue blanket exclusions for anti-obesity drugs. This puts Nevada ahead of most states in mandated commercial coverage.

Las Vegas and Reno Provider Landscape

The Las Vegas metro area has the highest concentration of weight management providers in Nevada. Several bariatric surgery centers have added GLP-1 programs, and concierge medicine practices along the Strip corridor cater to both residents and medical tourists. Reno has growing options through Renown Health and affiliated specialists. Telehealth fills the gap for the rest of the state.

Las Vegas: 20+ obesity medicine specialists within Clark County
Reno: Renown Health system and several independent weight loss clinics
Rural Nevada: Telehealth is often the only practical access point
Medical tourism: Some Las Vegas practices offer cash-pay GLP-1 packages

Compounding Pharmacy Access

Nevada Board of Pharmacy licenses both 503A and 503B compounding facilities. Several Las Vegas-area compounding pharmacies prepare semaglutide formulations. Out-of-state 503B outsourcing facilities can also ship to Nevada. The cost differential between brand-name and compounded GLP-1s is substantial, making compounding a popular choice for cash-pay patients.

FAQ

Frequently Asked Questions

No. Nevada allows GLP-1 prescriptions through telehealth without a prior in-person visit. A video consultation with a licensed provider is sufficient to establish the patient-provider relationship.

Yes. Since AB 317 (2023), commercial health insurers in Nevada must cover FDA-approved anti-obesity medications. Prior authorization is still allowed, but blanket exclusions are prohibited.

Compounded semaglutide typically costs $150-$450/month in Nevada, compared to $900-$1,400 for brand-name Wegovy or Ozempic without insurance.

Yes. Telehealth platforms serve all Nevada ZIP codes, making GLP-1 access available even in remote areas like Elko, Winnemucca, and Ely. Medications ship directly to your home.

Nevada Medicaid covers GLP-1s for type 2 diabetes. Coverage for weight management is expanding but still requires prior authorization with documented BMI criteria and comorbidity evidence.